These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27010157)

  • 1. A multi-centre, open label, long-term follow-up study to evaluate the benefits of a new viscoelastic hydrogel (Hymovis®) in the treatment of knee osteoarthritis.
    Benazzo F; Perticarini L; Padolino A; Castelli A; Gifuni P; Lovato M; Manzini C; Giordan N
    Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):959-68. PubMed ID: 27010157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronan derivative HYMOVIS® increases cartilage volume and type ii collagen turnover in osteoarhritic knee: data from MOKHA study.
    Henrotin Y; Bannuru R; Malaise M; Ea HK; Confavreux C; Bentin J; Urbin-Choffray D; Conrozier T; Brasseur JP; Thomas P; Hick AC; Marinello A; Giordan N; Richette P
    BMC Musculoskelet Disord; 2019 Jun; 20(1):293. PubMed ID: 31215422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HYADD 4 versus methylprednisolone acetate in symptomatic knee osteoarthritis: a single-centre single blind prospective randomised controlled clinical study with 1-year follow-up.
    Bisicchia S; Bernardi G; Tudisco C
    Clin Exp Rheumatol; 2016; 34(5):857-863. PubMed ID: 27244700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring determinants predicting response to intra-articular hyaluronic acid treatment in symptomatic knee osteoarthritis: 9-year follow-up data from the Osteoarthritis Initiative.
    Pelletier JP; Raynauld JP; Abram F; Dorais M; Delorme P; Martel-Pelletier J
    Arthritis Res Ther; 2018 Mar; 20(1):40. PubMed ID: 29490683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NASHA hyaluronic acid vs. methylprednisolone for knee osteoarthritis: a prospective, multi-centre, randomized, non-inferiority trial.
    Leighton R; Akermark C; Therrien R; Richardson JB; Andersson M; Todman MG; Arden NK;
    Osteoarthritis Cartilage; 2014 Jan; 22(1):17-25. PubMed ID: 24185114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee.
    Petrella RJ; Petrella M
    J Rheumatol; 2006 May; 33(5):951-6. PubMed ID: 16652426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and performance of Hydros and Hydros-TA for knee osteoarthritis: a prospective, multicenter, randomized, double-blind feasibility trial.
    Petrella RJ; Emans PJ; Alleyne J; Dellaert F; Gill DP; Maroney M
    BMC Musculoskelet Disord; 2015 Mar; 16():57. PubMed ID: 25887932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized saline-controlled trial of NASHA hyaluronic acid for knee osteoarthritis.
    Arden NK; Åkermark C; Andersson M; Todman MG; Altman RD
    Curr Med Res Opin; 2014 Feb; 30(2):279-86. PubMed ID: 24168077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overall tolerability and analgesic activity of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis.
    Theiler R; Brühlmann P
    Curr Med Res Opin; 2005 Nov; 21(11):1727-33. PubMed ID: 16307692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of retreatment with a bioengineered hyaluronate for painful osteoarthritis of the knee: results of the open-label Extension Study of the FLEXX Trial.
    Altman RD; Rosen JE; Bloch DA; Hatoum HT
    Osteoarthritis Cartilage; 2011 Oct; 19(10):1169-75. PubMed ID: 21820521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Single Intra-Articular Injection of Novel Hyaluronan (HYA-JOINT Plus) with Synvisc-One for Knee Osteoarthritis: A Randomized, Controlled, Double-Blind Trial of Efficacy and Safety.
    Sun SF; Hsu CW; Lin HS; Liou IH; Chen YH; Hung CL
    J Bone Joint Surg Am; 2017 Mar; 99(6):462-471. PubMed ID: 28291178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-Hoc analysis of a head-to-head hyaluronic acid comparison in knee osteoarthritis using the 2004 OMERACT-OARSI responder criteria.
    Onel E; Kolsun K; Kauffman JI
    Clin Drug Investig; 2008; 28(1):37-45. PubMed ID: 18081359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical response to intra-articular injections of hylan G-F 20 in symptomatic hip osteoarthritis: the OMERACT-OARSI criteria applied to the results of a pilot study.
    Conrozier T; Bertin P; Bailleul F; Mathieu P; Charlot J; Vignon E; Treves R; Chevalier X
    Joint Bone Spine; 2006 Dec; 73(6):705-9. PubMed ID: 16997602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open-label study of a second course of hylan G-F 20 for the treatment of pain associated with knee osteoarthritis.
    Waddell DD; Cefalu CA; Bricker DC
    Curr Med Res Opin; 2003; 19(6):499-507. PubMed ID: 14594522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of high molecular weight hyaluronic acid for knee osteoarthritis in patients in the working age: a randomised controlled trial.
    Hermans J; Bierma-Zeinstra SMA; Bos PK; Niesten DD; Verhaar JAN; Reijman M
    BMC Musculoskelet Disord; 2019 May; 20(1):196. PubMed ID: 31064359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial).
    Altman RD; Rosen JE; Bloch DA; Hatoum HT; Korner P
    Semin Arthritis Rheum; 2009 Aug; 39(1):1-9. PubMed ID: 19539353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicentre, prospective, open study to evaluate the safety and efficacy of hylan G-F 20 in knee osteoarthritis subjects presenting with pain following arthroscopic meniscectomy.
    Huskin JP; Vandekerckhove B; Delincé P; Verdonk R; Dubuc JE; Willems S; Hardy P; Blanco FJ; Charrois O; Handelberg F
    Knee Surg Sports Traumatol Arthrosc; 2008 Aug; 16(8):747-52. PubMed ID: 18536906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of polyacrylamide hydrogel injection for knee osteoarthritis: results from a 12-month follow up of an open-label study.
    Bliddal H; Beier J; Hartkopp A; Conaghan PG; Henriksen M
    J Orthop Surg Res; 2024 May; 19(1):274. PubMed ID: 38698396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus Durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: a randomized controlled trial.
    Vaquerizo V; Plasencia MÁ; Arribas I; Seijas R; Padilla S; Orive G; Anitua E
    Arthroscopy; 2013 Oct; 29(10):1635-43. PubMed ID: 24075613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Efficacy of Intra-Articular HYADD® 4 (Hymovis®) Injections for Symptomatic Knee Osteoarthritis.
    Priano F
    Joints; 2017 Jun; 5(2):79-84. PubMed ID: 29114635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.